Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in KAPA held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 232K | $130K | — | 1.083% | 0.00% |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 111K | $62K | +52.8% | 0.520% | 0.00% |
| 3 | VANGUARD FIDUCIARY TRUST CO | 64K | $36K | — | 0.298% | 0.00% |
| 4 | SevenBridge Financial Group, LLC | 44K | $30K | 0.0% | 0.207% | 0.00% |
| 5 | Aptus Capital Advisors, LLC | 44K | $25K | 0.0% | 0.207% | 0.00% |
| 6 | TWO SIGMA INVESTMENTS, LP | 40K | $22K | -57.9% | 0.185% | 0.00% |
| 7 | STATE STREET CORP | 24K | $13K | 0.0% | 0.113% | 0.00% |
| 8 | TWO SIGMA SECURITIES, LLC | 16K | $9K | — | 0.076% | 0.00% |
| 9 | Tower Research Capital LLC (TRC) | 4K | $2K | -6.3% | 0.018% | 0.00% |
| 10 | HRT FINANCIAL LP | 22K | $12 | +1.2% | 0.101% | 0.00% |
| 11 | CITIGROUP INC | 10 | $6 | — | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in KAPA — a direct measure of their conviction.
Filings activity in KAPA during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new KAPA position in Q1 2026
Institutions that fully closed their KAPA position in Q1 2026
7 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 11 | 21% | 3.50% | 2.64 pp | $0M | 43% |
| Q4 2025 | 14 | +7.7% | 6.14% | +1.06 pp | $1M | +21% |
| Q3 2025 | 13 | +30% | 5.08% | +3.87 pp | $0M | +319% |
| Q2 2025 | 10 | +11% | 1.21% | 14.32 pp | $0M | 92% |
| Q1 2025 | 9 | +50% | 15.53% | +9.19 pp | $1M | +145% |
| Q4 2024 | 6 | +100% | 6.34% | +6.34 pp | $1M | +853176% |
| Q3 2024 | 3 | — | 0.00% | — | $0M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying KAPA stock.
Based on Q1 2026 13F filings, institutional ownership of Kairos Pharma, Ltd. stands at 3.5%, held across 11 reporting institutions.
VANGUARD CAPITAL MANAGEMENT LLC is the largest reported institutional holder of KAPA, with approximately 231,878 shares worth $0.00B as of Q1 2026.
Yes — 2 widely-followed marquee investors appear among the top 25 institutional holders of KAPA, including TWO SIGMA INVESTMENTS, LP, TWO SIGMA SECURITIES, LLC.
Our composite Smart Money Score for KAPA is 37 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
4 institutions opened new positions in KAPA during Q1 2026, while 7 fully exited. 1 added to existing positions and 6 trimmed.
KAPA institutional ownership fell by 2.64 percentage points quarter-over-quarter, with a net change of -3 holders.
The top 10 institutions account for 100.0% of all reported 13F value in KAPA, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Kairos Pharma, Ltd. (KAPA) Institutional Ownership